The medical landscape for diabetes is shifting, and these patches represent a promising advance. Unlike subcutaneous injections, this approach offers a more convenient way to provide GLP-1 drugs. These devices slowly release the treatment through the epidermis offering a consistent level of the active agent, which can enhance blood sugar regulation